Citadel Advisors’s Nobilis Health Corp. HLTH Stock Holding History

Citadel Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,100	Closed	-$8K	–	10275
2019 Q1	$8K	Buy	23,100 +400	+2%	+$165	﹤0.01%	9163
2018 Q4	$10K	Buy	+22,700	New	+$13.4K	﹤0.01%	8932
2017 Q3	–	Sell	-14,100	Closed	-$27K	–	8345
2017 Q2	$27K	Buy	14,100 +500	+4%	+$757	﹤0.01%	7235
2017 Q1	$23K	Sell	13,600 -3,000	-18%	-$6.24K	﹤0.01%	7221
2016 Q4	$35K	Sell	16,600 -14,100	-46%	-$38.4K	﹤0.01%	6954
2016 Q3	$103K	Buy	+30,700	New	+$92.3K	﹤0.01%	6646

Other funds holding HLTH

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors's HLTH Position: Q3 2019 in Review

Citadel Advisors sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 54,667 shares — an estimated $8K sold.

Citadel Advisors first reported a position in HLTH in Q1 2016 and held it in 6 quarters. The position peaked at $82K in Q1 2018. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.

Citadel Advisors reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
Citadel Advisors sold 54,667 Nobilis Health Corp. shares in Q3 2019, an estimated $8K.
Citadel Advisors first reported a position in Nobilis Health Corp. in Q1 2016 and held it in 6 quarters.
Citadel Advisors's Nobilis Health Corp. position peaked at $82K in Q1 2018.
3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.